Analysis reveals carbamoyl carboxylic acid analogues enhance binding to arginine kinase in ticks, suggesting new control methods.
Ticks transmit diseases and harm animals worldwide, and their control primarily relies on pesticides. Resistance to these pesticides has developed consistently over centuries. Arginine Kinase (AK, EC 2.7.3.3) is a conserved, ancestral enzyme that provides reserve energy in emergency situations and a viable target for novel antiparasitic drugs. Our aim was to evaluate six carbamoyl carboxylic acid analogues (CCAs) as potential lead compounds by investigating their interaction with the active site of Rhipicephalus sanguineus AK (RsAK) using a structural modeling approach. The binding was characterized using fluorescence quenching (Stern–Volmer analysis) and molecular dynamics simulations. The simulations, performed with GROMACS using the CHARMM 26 force field over 100 ns, provided atomic-level insight into the ligand–protein interactions and stability. CCA4 exhibited the lowest dissociation constant (KD~13·10−6 M) among the analogues, which we attribute to its end moieties (carboxylate and a pyridine on the ends). Purely aromatic ends (CCA1) or those with dual carboxylates (CCA6) showed lower affinity, suggesting that electrostatic complementarity and steric fit are processes involved in the binding. Despite requiring optimization, the CCA scaffold represents a novel strategy for tick control. These compounds provide a foundation for developing synergistic agents to enhance the efficacy of sustainable acaricides.
No takes yet. Share an insight, caveat, or question.
Rojas et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: